FSU research produces images of AIDS virus that may shape vaccine

May 26, 2006

TALLAHASSEE, Fla. -- As the world marks the 25th year since the first diagnosed case of AIDS, groundbreaking research by scientists at Florida State University has produced remarkable three-dimensional images of the virus and the protein spikes on its surface that allow it to bind and fuse with human immune cells.

Findings from this AIDS research could boost the development of vaccines that will thwart infection by targeting and crippling the sticky HIV-1 spike proteins. In fact, said principal investigator and FSU Professor Kenneth H. Roux, at least two laboratories already are crafting vaccine candidates based on preliminary results uncovered by his team of structural biologists.

Those results are described in the online edition of the journal Nature.

Never before generated in such intricate detail, the super-sized images of the virus and its viral spikes have given researchers their first good look at the pathogen's complex molecular surface architecture that facilitates the infection process.

"Until now, despite intensive study by many laboratories, the design details of the spikes and their distribution pattern on the surface of the virus membrane have been poorly understood, which has limited our understanding of how the virus infection actually occurs and frustrated efforts to create vaccines," Roux said.

To produce the images, research associate Ping Zhu, Roux, and their colleagues used a state-of-the art technique called cryoelectron microscopy tomography. It generates three-dimensional images similar to those from a CAT scan, but at the level of viruses and molecules rather than tissues and organs.

They imaged HIV samples as well as a mutant SIV (non-human primate) strain, genetically engineered for the study by collaborators at the National Cancer Institute to express about 74 spikes as opposed to the 14 found on the HIV virus -- more spikes make it easier to work with. The virus samples were suspended in a thin liquid film stretched across the holes of a small copper grid and then flash-frozen, creating a solid form of ice that is more like clear glass than the typical crystalline form in ice cubes.

Once inside the electron microscope, electrons bombarded the samples from myriad angles, magnifying it more than 43,000 times to reveal its surprising structure -- absent the degree of distortion caused by the more typical imaging methods involving drying and staining of specimens.

As a result, the researchers were able to hone in on the envelope -- the lipid membrane covering the virus itself. They imaged the spikes protruding from the envelope, which contain the only viral protein molecules on the HIV surface. The FSU scientists also were able to capture super-sized images of both the head of the spike and its supporting stalk. The spike head is responsible for binding the virus to the target cell. Its stalk is responsible for the fusion event in which HIV injects its genes into the human host cells for which the virus has a natural affinity -- T lymphocytes and macrophages.

"Antibodies that effectively bind to either of these spike parts will neutralize the virus to prevent infection," said Roux, a member of FSU's biological science faculty since 1978.

His biggest surprise: the stalk has legs.

"Researchers thought the spike stalk was comprised of a tight collection of three rods bound together with the head of the spike perched on top. But our images reveal that the stalk is split into three legs, spread more like a tripod, which increases their contact with the viral membrane," Roux said. "Seeing the tripod stalk suggests a novel mechanism by which HIV-1 is able to so effectively fuse with our cells. That essential knowledge should help us design better weapons to fight the virus."

FSU Arts and Sciences Dean Joseph Travis has declared the work "a beautiful example of what happens when strong, sound basic science is applied to a very difficult problem."

The National Institutes of Health funded the two-year study, conducted by members of the department of biological science and the Institute of Molecular Biophysics at FSU.

AIDS has produced one of the worst pandemics ever known. About 25 million people have died and 40 million are infected worldwide -- including 1 million in the United States.
-end-
By Libby Fairhurst

For digital images, call (850) 644-4030

To listen to a Nature podcast featuring Roux, visit its Web site and follow instructions at: http://www.nature.com/nature/podcast/index.html

From Florida State University's biological science department and Institute of Molecular Biophysics, co-authors of "Distribution and three-dimensional structure of AIDS virus envelope spikes" are: Professor Kenneth Roux (principal investigator), Professor Kenneth A. Taylor, Ping Zhu, Jun Liu and Henry Grise. Other co-authors are Jeffrey D. Lifson, Julian Bess, Jr. and Elena Chertova (AIDS Vaccine Program, SAIC Frederick, Inc., National Cancer Institute, Frederick, Md.); and Gilad A. Ofek (Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.).

Florida State University

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.